Betamethasone/Calcipotriol Uses

sponsored
What is the dose of your medication?

What is Betamethasone/Calcipotriol?

Betamethasone/Calcipotriol contains a combination of betamethasone and calcipotriene. Betamethasone is a steroid. It prevents the release of substances in the body that cause inflammation. Calcipotriene is a form of vitamin D. It works by decreasing the rate of skin cell reproduction.

Betamethasone/Calcipotriol topical (for the skin) is a combination medicine used to treat plaque psoriasis.

Adults may use the suspension (liquid) form of this medicine on the skin or the scalp. The liquid may be used only on the scalp in children who are at least 12 years old.

Betamethasone/Calcipotriol topical ointment should be used only on the skin and only by adults.

Betamethasone/Calcipotriol indications

infoAn indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Betamethasone/Calcipotriol® (calcipotriene and betamethasone dipropionate) Ointment is indicated for the topical treatment of psoriasis vulgaris in adults 18 years of age and above for up to 4 weeks. The maximum weekly dose should not exceed 100 g. Treatment of more than 30% body surface area is not recommended.

Betamethasone/Calcipotriol® (calcipotriene and betamethasone dipropionate) Ointment should not be applied to the face, axillae or groin.

How should I use Betamethasone/Calcipotriol?

infoThere are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.

Use Betamethasone/Calcipotriol exactly as it was prescribed for you. Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended. Do not use Betamethasone/Calcipotriol to treat any condition that has not been checked by your doctor.

Do not take Betamethasone/Calcipotriol by mouth.

Topical medicine is for use only on the skin. Do not use in the vagina.

Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.

Wash your hands before and after applying this medicine, unless you are using the medicine to treat the skin on your hands.

Shake the Betamethasone/Calcipotriol suspension (liquid) just before using it.

Apply Betamethasone/Calcipotriol once daily to the affected skin and rub it in gently. Do not spread the medicine over a large skin area. Do not apply to areas of thinner skin (face, underarms, groin) unless your doctor tells you to.

Do not cover the treated skin area. Covering skin treated with a topical steroid can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects.

If you use Betamethasone/Calcipotriol liquid:

  • Adults should not use more than 100 grams (1 full bottle) of the liquid in 1 week.

  • Children age 12 and older should not use more than 60 grams of the liquid in 1 week.

If you use Betamethasone/Calcipotriol ointment: Do not use more than 100 grams (1 large tube) of the ointment in 1 week. Avoid treating an area that is larger than 30% or one-third of your entire body.

Ask your pharmacist if you have questions about how much to apply each time you use the medicine.

Betamethasone/Calcipotriol ointment can be applied daily for up to 4 weeks. The liquid can be used daily for up to 8 weeks. Follow your doctor's instructions about your individual treatment schedule.

Call your doctor if your skin condition does not improve after several days of treatment, or if it gets worse while using this medicine.

If you use Betamethasone/Calcipotriol long-term, you may need frequent medical tests.

Store at room temperature away from moisture and heat. Keep the bottle or tube tightly closed when not in use.

Stop using Betamethasone/Calcipotriol when your skin clears up, unless your doctor tells you otherwise.

Betamethasone/Calcipotriol description

sponsored

Each gram of ointment contains calcipotriol 50 mcg and betamethasone dipropionate 0.5 mg.

Each gram of Betamethasone/Calcipotriol gel contains calcipotriol monohydrate 50 mcg and betamethasone dipropionate 0.5 mg. It also contains the following excipients: Liquid paraffin, butylhydroxytoluene (E321), polyoxypropylene-15 stearyl ether, all-rac-α-tocopherol, hydrogenated castor oil.

Betamethasone/Calcipotriol dosage

Instruct patients to shake can prior to using Betamethasone/Calcipotriol® Foam and to wash their hands after applying the product.

Apply Betamethasone/Calcipotriol® Foam to affected areas once daily for up to 4 weeks. Rub in Betamethasone/Calcipotriol® Foam gently. Discontinue use when control is achieved.

Instruct patients not to use more than 60 g every 4 days.

Betamethasone/Calcipotriol® Foam should not be used with occlusive dressings unless directed by a physician. Betamethasone/Calcipotriol® Foam is not for oral, ophthalmic, or intravaginal use.

Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site.

How supplied

Dosage Forms And Strengths

Foam, 0.005%/0.064%

Betamethasone/Calcipotriol® Foam is a white to off-white opalescent liquid in a pressurized aluminum spray can with a continuous valve and actuator. At administration the product is a white to off-white foam after evaporation of the propellants. Each gram of Betamethasone/Calcipotriol® Foam contains 52.2 mcg calcipotriene hydrate (equivalent to 50 mcg of calcipotriene) and 0.643 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone).

Storage And Handling

Betamethasone/Calcipotriol® Foam is a white to off-white opalescent liquid in a pressurized aluminum spray can with a continuous valve and actuator. At administration the product is a white to off-white foam after evaporation of the propellants.

Betamethasone/Calcipotriol® Foam is available in aluminum cans of:

1 x 60 g (NDC 50222-302-60)

2 x 60 g (NDC 50222-302-66)

Storage
  • Store Betamethasone/Calcipotriol® Foam at 20 °- 25°C (68° -77°F); excursions pe rmitted between 15 °-30°C (59°-86°F).
  • Contents under pressure. Do not puncture or incinerate. Do not expose to heat or store at temperatures above 120°F (49°C). Do not freeze.
  • The product should be used within six m onths after it has been opened.
Handling
  • Betamethasone/Calcipotriol® Foam is flammable; avoid heat, flame or smoking when using this product.

Manufactured by: Colep Laupheim GmbH & Co. KG Fockestra

Betamethasone/Calcipotriol interactions

See also:
What other drugs will affect Betamethasone/Calcipotriol?

sponsored

No interaction studies have been performed.

Incompatibilities: In the absence of compatibility studies, Betamethasone/Calcipotriol gel must not be mixed with other medicinal products.

Betamethasone/Calcipotriol side effects

See also:
What are the possible side effects of Betamethasone/Calcipotriol?

The trial programme for Betamethasone/Calcipotriol ointment has so far included >2500 patients for Betamethasone/Calcipotriol ointment and >4,700 patients for Betamethasone/Calcipotriol Gel and has shown that approximately 10% and 8% of patients can be expected to experience a non-serious undesirable effect for Betamethasone/Calcipotriol Gel and Ointment, respectively.

Based on data from clinical trials and post-market use, the common undesirable effects are pruritus, rash and burning sensation of skin. Uncommon undesirable effects are skin pain or irritation, dermatitis, erythema, exacerbation of psoriasis, folliculitis and application site pigmentation changes. Pustular psoriasis is a rare undesirable effect.

The individual undesirable effects are listed as follows, starting with the most frequently reported:

Skin and Subcutaneous Tissue Disorders: Common (>1/100 and <1/10): Pruritus, rash, burning sensation of skin. Uncommon (>1/1000 and <1/100): Skin pain or irritation, dermatitis, erythema, exacerbation of psoriasis, folliculitis, application site pigmentation changes. Rare (>1/10,000 and <1/1000): Pustular psoriasis.

Undesirable effects observed for calcipotriol and betamethasone, respectively:

Calcipotriol: Undesirable effects include application site reactions, pruritus, skin irritation, burning and stinging sensations, dry skin, erythema, rash, dermatitis, eczema, aggravated psoriasis, photosensitivity and hypersensitivity reactions including very rare cases of angioedema and facial oedema. Systemic effects after topical use may appear very rarely causing hypercalcaemia or hypercalciuria.

Betamethasone (as Dipropionate): Betamethasone/Calcipotriol contains a potent corticosteroid.

Local reactions can occur after topical use, especially during prolonged application, including skin atrophy, telangiectasia, striae, folliculitis, hypertrichosis, perioral dermatitis, allergic contact dermatitis, depigmentation and colloid milia. When treating psoriasis, there may be a risk of generalised pustular psoriasis.

Systemic effects due to topical use of corticosteroids are rare in adults, however they can be severe. Adrenocortical suppression, cataract, infections and increase of intraocular pressure can occur, especially after long-term treatment. Systemic effects occur more frequently when applied under occlusion (plastic, skin folds), when applied on large areas and during long-term treatment.

Betamethasone/Calcipotriol contraindications

See also:
What is the most important information I should know about Betamethasone/Calcipotriol?

sponsored

Hypersensitivity to calcipotriol monohydrate or betamethasone dipropionate gel or to any of the excipients of Betamethasone/Calcipotriol.

Due to the content of calcipotriol, Betamethasone/Calcipotriol gel is contraindicated in patients with known disorders of calcium metabolism.

Due to the content of corticosteroid, Betamethasone/Calcipotriol gel is contraindicated in the following conditions: Viral (eg, herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis or syphilis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers and wounds.

Betamethasone/Calcipotriol gel is contraindicated in guttate, erythrodermic, exfoliative and pustular psoriasis. It is also contraindicated in patients with severe renal insufficiency or severe hepatic disorders.

Active ingredient matches for Betamethasone/Calcipotriol:

Betamethasone/Calcipotriol


List of Betamethasone/Calcipotriol substitutes (brand and generic names)

Sort by popularity
Unit description / dosage (Manufacturer)Price, USD
Ointment; Topical; Betamethasone Dipropionate 0.05%; Calcipotriol Hydrate 0.005% (Win Medicare Pvt Ltd)
Daivobet Calcipotriol 50 mcg, Betamethasone 0.5 mg/1 g. OINT / 15g (Win Medicare Pvt Ltd)$ 12.91
Daivobet 15 g (Win Medicare Pvt Ltd)$ 22.24
Daivobet 15 g x 1's (Win Medicare Pvt Ltd)$ 23.93
Daivobet 30 g (Win Medicare Pvt Ltd)$ 38.37
Daivobet 1 tube 15 g (Win Medicare Pvt Ltd)
15g (Win Medicare Pvt Ltd)$ 12.91
Daivobet Skin 15 gm Ointment (Win Medicare Pvt Ltd)$ 0.82
Daivobet oint 15 g x 1's (Win Medicare Pvt Ltd)$ 22.91
Daivobet oint 30 g x 1's (Win Medicare Pvt Ltd)$ 41.18
Daivobet gel 15 g x 1's (Win Medicare Pvt Ltd)
Daivobet gel 30 g x 1's (Win Medicare Pvt Ltd)$ 41.98
Daivobet gel 60 g x 1's (Win Medicare Pvt Ltd)
DAIVOBET oint 15g (Win Medicare Pvt Ltd)$ 12.29

References

  1. DailyMed. "CALCIPOTRIENE HYDRATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. DailyMed. "BETAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  3. PubChem. "betamethasone". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Betamethasone/Calcipotriol are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Betamethasone/Calcipotriol. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 6 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2020 ndrugs.com All Rights Reserved